CytoSorbents 2021: Leadership and Growth in the “New Normal”
MONMOUTH JUNCTION, N.J., Feb. 18, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,…
Comments Off on CytoSorbents 2021: Leadership and Growth in the “New Normal”